NCT07045623 Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
| NCT ID | NCT07045623 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Saint Vincent's Hospital, Korea |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 348 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 348 participants in total. It began in 2025-04-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The prevalence of dyslipidemia is high among patients with hypertension and diabetes mellitus, which increases the risk of cardiovascular disease. However, many patients lack awareness and adherence to treatment and lifestyle modifications. Therefore, a more structured and intensive approach to management and education is required. This study aims to implement intensive dyslipidemia management and education for patients registered at the Hanam City Hypertension and Diabetes Education Center and evaluate changes in blood lipid levels accordingly. Additionally, the study will analyze the impact of intensive education on patients' quality of life, health behaviors, and treatment adherence, ultimately contributing to the development of effective management strategies.
Eligibility Criteria
Inclusion Criteria: * Patients registered in the Hanam City Hypertension and Diabetes Program * Adults aged 30 to 80 years * Individuals who have provided written informed consent to participate in the study Exclusion Criteria: * Chronic kidney disease stage 4 or higher (eGFR \<30 mL/min/1.73m²) * Patients with liver cirrhosis or severe liver disease * Patients with a history of acute coronary syndrome within the past 6 months * Pregnant or breastfeeding women • Individuals with psychiatric disorders that may affect study participation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07045623 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07045623 currently recruiting?
Yes, NCT07045623 is actively recruiting participants. Contact the research team at hhhsungho@naver.com for enrollment information.
Where is the NCT07045623 trial being conducted?
This trial is being conducted at Gyeonggi-do, South Korea.
Who is sponsoring the NCT07045623 clinical trial?
NCT07045623 is sponsored by Saint Vincent's Hospital, Korea. The trial plans to enroll 348 participants.